- Home
- ALRM vs TYRA Comparison
ALRM vs TYRA Comparison
Compare ALRM & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALRM | TYRA |
|---|---|---|
| Founded | 2000 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ALRM | TYRA |
|---|---|---|
| Price | $43.92 | $32.94 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $56.67 | $47.50 |
| AVG Volume (30 Days) | 420.6K | ★ 731.1K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.42 | N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $1,011,187,000.00 | N/A |
| Revenue This Year | $7.00 | N/A |
| Revenue Next Year | $4.53 | N/A |
| P/E Ratio | $92.85 | ★ N/A |
| Revenue Growth | ★ 7.59 | N/A |
| 52 Week Low | $41.49 | $8.75 |
| 52 Week High | $59.98 | $40.65 |
Technical Indicators
Market Signals| Indicator | ALRM | TYRA |
|---|---|---|
| Relative Strength Index (RSI) | 47.17 | 42.25 |
| Support Level | $42.16 | $30.10 |
| Resistance Level | $52.52 | $33.99 |
| Average True Range (ATR) | 1.71 | 1.95 |
| MACD | -0.07 | -0.22 |
| Stochastic Oscillator | 33.03 | 18.16 |
Price Performance
Historical ComparisonAbout ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.